Escalated doses of lomitapide (5–10 mg/day; orally) with or without ezetimibe have been tested in patients with moderate hypercholesterolemia for a period of 12 weeks. The results indicated a ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients ...

No writing assistance was utilized in the production of this manuscript. Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Early ...

Familial Hypercholesterolemia "The justly celebrated unraveling of the LDL receptor pathway revealed that mutations in a ...

Heterozygous familial hypercholesterolemia was associated with increased type 2 diabetes risk, especially among those with obesity and statin use.

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

Considering taking supplements to treat hypercholesterolemia? Below is a list of common natural remedies used to treat or reduce the symptoms of hypercholesterolemia. Follow the links to read ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...